Ken Griffin's position in Royalty Pharma plc is currently worth $95.9 Million. That's 0.10% of their equity portfolio (264th largest holding). The first Royalty Pharma plc trade was made in Q2 2020. Since then Ken Griffin bought shares nine more times and sold shares on seven occasions. The stake costed the investor $76.8 Million, netting the investor a gain of 25% so far.